Literature DB >> 6435605

Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448.

P R Sinclair, W J Bement, H L Bonkovsky, J F Sinclair.   

Abstract

Uroporphyrinogen decarboxylase (EC 4.1.1.37) activity was assayed in cultures of chick-embryo hepatocytes by the changes in composition of porphyrins accumulated after addition of excess 5-aminolaevulinate. Control cells accumulated mainly protoporphyrin, whereas cells treated with 3,4,3',4'-tetrachlorobiphenyl or 2,4,5,3',4'-pentabromobiphenyl accumulated mainly uroporphyrin, indicating decreased activity of the decarboxylase. 3-Methylcholanthrene and other polycyclic-hydrocarbon inducers of the P-448 isoenzyme of cytochrome P-450, did not affect the decarboxylase in the absence of the biphenyls. Induction of P-448 was detected as an increase in ethoxyresorufin de-ethylase activity. Pretreatment of cells with methylcholanthrene decreased the time required for the halogenated biphenyls to inhibit the decarboxylase. The dose response of methylcholanthrene showed that less than 40% of the maximal induction of cytochrome P-448 was needed to produce the maximum biphenyl-mediated inhibition of the decarboxylase. In contrast, induction of the cytochrome P-450 isoenzyme by propylisopropylacetamide had no effect on the biphenyl-mediated decrease in decarboxylase activity. Use of inhibitors of the P-450 and P-448 isoenzymes (SKF-525A, piperonyl butoxide and ellipticine) supported the concept that only the P-448 isoenzyme is involved in the inhibition of the decarboxylase by the halogenated biphenyls. The effect of preinduction with methylcholanthrene to enhance inhibition of the decarboxylase was also shown by the increased rate at which porphyrin accumulated from endogenously synthesized 5-aminolaevulinate after treatment of cells with the combination of propylisopropylacetamide and the biphenyls. Antioxidants, chelators of iron, and chromate affected the decrease in decarboxylase activity only if they prevented the induced increase in cytochrome P-448. We conclude that the P-448 and not the P-450 isoenzyme of cytochrome P-450 plays an obligatory role in the inhibition of uroporphyrinogen decarboxylase caused by halogenated biphenyls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435605      PMCID: PMC1144237          DOI: 10.1042/bj2220737

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition.

Authors:  S Granick; P Sinclair; S Sassa; G Grieninger
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

2.  The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat.

Authors:  G H Elder; J O Evans; S A Matlin
Journal:  Clin Sci Mol Med       Date:  1976-07

Review 3.  Multiplicity of mammalian microsomal cytochromes P-45.

Authors:  A Y Lu; S B West
Journal:  Pharmacol Rev       Date:  1979-12       Impact factor: 25.468

4.  Decreased uroporphyrinogen decarboxylase activity in 'experimental symptomatic porphyria'.

Authors:  J J Taljaard; B C Shanley; S M Joubert
Journal:  Life Sci II       Date:  1971-08

5.  The metabolism of aminopyrine in chick embryo hepatic cell culture: effects of competitive substrates and carbon monoxide.

Authors:  A Poland; A Kappas
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

6.  Drug-mediated induction of cytochrome(s) P-450 and drug metabolism in cultured hepatocytes maintained in chemically defined medium.

Authors:  F R Althaus; J F Sinclair; P Sinclair; U A Meyers
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

7.  Uroporphyrin formation induced by chlorinated hydrocarbons (lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin). Requirements for endogenous iron, protein synthesis and drug-metabolizing activity.

Authors:  P R Sinclair; S Granick
Journal:  Biochem Biophys Res Commun       Date:  1974-11-06       Impact factor: 3.575

8.  Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo(p)dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness.

Authors:  K G Jones; G D Sweeney
Journal:  Toxicol Appl Pharmacol       Date:  1980-03-30       Impact factor: 4.219

9.  A class of strong inhibitors of microsomal monooxygenases: the ellipticines.

Authors:  P Lesca; E Rafidinarivo; P Lecointe; D Mansuy
Journal:  Chem Biol Interact       Date:  1979-02       Impact factor: 5.192

10.  Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria.

Authors:  B Grandchamp; J C Deybach; M Grelier; H de Verneuil; Y Nordmann
Journal:  Biochim Biophys Acta       Date:  1980-05-22
View more
  17 in total

Review 1.  Review: porphyrins as biomarkers for hazard assessment of bird populations: destructive and non-destructive use.

Authors:  Silvia Casini; M Cristina Fossi; Claudio Leonzio; Aristeo Renzoni
Journal:  Ecotoxicology       Date:  2003 Feb-Aug       Impact factor: 2.823

2.  Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide.

Authors:  P R Sinclair; W J Bement; H L Bonkovsky; R W Lambrecht; J E Frezza; J F Sinclair; A J Urquhart; G H Elder
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

3.  Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.

Authors:  P R Sinclair; N Gorman; T Dalton; H S Walton; W J Bement; J F Sinclair; A G Smith; D W Nebert
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.

Authors:  H L Bonkovsky; J F Healey; P R Sinclair; J F Sinclair
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

5.  Does dietary copper supplementation enhance or diminish PCB126 toxicity in the rodent liver?

Authors:  Ian K Lai; William D Klaren; Miao Li; Brian Wels; Donald L Simmons; Alicia K Olivier; Wanda M Haschek; Kai Wang; Gabriele Ludewig; Larry W Robertson
Journal:  Chem Res Toxicol       Date:  2013-04-15       Impact factor: 3.739

6.  Inhibition of ethoxyresorufin-O-deethylase (EROD) activity in mixtures of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyls : EROD acitivity as biomarker in TCDD and PCB risk assessment.

Authors:  M Tysklind; A B Bosveld; P Andersson; E Verhallen; T Sinnige; W Seinen; C Rappe; M van den Berg
Journal:  Environ Sci Pollut Res Int       Date:  1995-07       Impact factor: 4.223

7.  Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.

Authors:  A G Smith; J E Francis
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

8.  Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid.

Authors:  A J Urquhart; G H Elder; A G Roberts; R W Lambrecht; P R Sinclair; W J Bement; N Gorman; J A Sinclair
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

9.  Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and in Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compounds.

Authors:  R W Lambrecht; P R Sinclair; W J Bement; J F Sinclair; H M Carpenter; D R Buhler; A J Urquhart; G H Elder
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

10.  Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.

Authors:  A G Smith; J E Francis; S J Kay; J B Greig; F P Stewart
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.